Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Norwegian Immunotherapy in Multiple Myeloma Study - A Population-based Longitudinal Observational Multicenter Study on Effectiveness and Complications of Immunotherapy in Multiple Myeloma in the Norwegian Myeloma Cohort

NCT06855121 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT06855121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Norwegian Immunotherapy in Multiple Myeloma Study - A Population-based Longitudinal Observational Multicenter Study on Effectiveness and Complications of Immunotherapy in Multiple Myeloma in the Norwegian Myeloma Cohort
Lead sponsor
St. Olavs Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 15, 2025
Completion date
December 1, 2037
Enrollment
400 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis, myeloma multiple, plasma cell leukemia